ClinicalTrials.gg
RecruitingNCT07872176Updated Oct 13, 2026

Application-Based Personalized Exercise Program in Older Adults

An interventional study of Application-Based Personalized Multicomponent Exercise Program in Physical Function in Older Adults, sponsored by Korea University Guro Hospital. Recruiting at 1 site in South Korea. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Korea University Guro Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled May 2023, registered Oct 2026).
  • Started May 2023; still recruiting 3 years 5 months later.
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

This study aims to evaluate the feasibility, usability, adherence, and potential effects of an application-based personalized multicomponent exercise program in older adults. Participants aged 65 years or older who are able to walk independently outdoors receive an individualized exercise program based on their baseline physical performance. The program includes resistance, aerobic, balance, and flexibility exercises delivered through a mobile application for approximately 30 minutes per session, 5 days per week, for 4 weeks. Exercise adherence is assessed using application-recorded exercise logs. Physical performance, balance, body composition, and perceived usability are also evaluated.

02

Conditions studied

  • Physical Function in Older Adults

Browse trials for

Keywords

  • Older Adults
  • Exercise
  • Mobile Application
03

In context

Motor Activity

2,646 studies on the registry are indexed under Motor Activity; 1,205 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 2,309 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Korea University Guro Hospital is the lead sponsor of 89 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age 65 years or older Mini-Mental State Examination (MMSE) score of 20 or higher Ability to ambulate independently outdoors

Exclusion criteria

Exclusion Criteria:

Cognitive impairment that may interfere with informed consent or participation in the exercise program Psychiatric disorders that may interfere with participation in the study Musculoskeletal disease, history of musculoskeletal surgery, or other medical conditions that, in the investigator's judgment, may preclude safe participation in the exercise program

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Application-Based Personalized Exercise Group

    Participants receive a personalized multicomponent exercise program delivered through a mobile application for approximately 30 minutes per session, 5 days per week, for 4 weeks. Exercise content is individualized according to baseline physical performance assessed using the Short Physical Performance Battery (SPPB).

    Behavioral: Application-Based Personalized Multicomponent Exercise Program

Interventions

  • BehavioralApplication-Based Personalized Multicomponent Exercise Program

    The intervention consists of resistance, aerobic, balance, and flexibility exercises delivered through a mobile application. Exercise content is personalized according to baseline SPPB performance. Participants perform approximately 30 minutes of exercise per session, 5 days per week, for 4 weeks. Exercise completion is recorded through application usage logs.

06

What researchers measure

Primary outcomes

  1. Exercise Adherence Rate

    Exercise adherence is calculated as the number of completed exercise sessions recorded in the application divided by the total number of prescribed exercise sessions (20 sessions), multiplied by 100. Higher percentages indicate greater adherence to the prescribed exercise program.

    Time frame: During the 4-week intervention

Secondary outcomes

  1. System Usability Scale Score

    Perceived usability of the application is assessed using the 10-item System Usability Scale (SUS). The total SUS score ranges from 0 to 100, with higher scores indicating greater perceived usability.

    Time frame: At the end of the 4-week intervention

07

Study locations

1 of 1 sites recruiting
  • Korea University Guro Hospital
    Seoul, South Korea
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Mar 2027, 46 months after the start.

Of 1,726 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 47. This study's planned 46 months is above that.

Counting every sponsor, half of 1,738 studies reached it within 23 months; a quarter within 9 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 7, 2026
First posted
Oct 13, 2026
StartActual
May 12, 2023
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872176
Lead sponsor
Korea University Guro Hospital
Responsible party
Jun, So Yeon (Clinical Assistant Professor, Korea University Guro Hospital) — Principal investigator
First posted
Oct 13, 2026
Start date
May 12, 2023
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

SY Jun, MD. PhD
Contact
rehabsy88@kumc.or.kr
+82-2-2626-1490

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion